Physician profile
Michael R Knight
NPI 1487852570
$4,804.40
in general payments reported to CMS, 2019-2025
27 companies · $905 in 2025
The $905 reported for 2025 was more than what a typical Trauma Surgery provider received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,353 · 2020: $271 · 2021: $530 · 2022: $473 · 2023: $695 · 2024: $577 · 2025: $905.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,178.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,177.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $1,780.28 | 2021-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Kls-Martin L.P. | $1,254.15 | 2019 | |
| Davol INC. | $293.42 | 2019-2022 | |
| Dilon Technologies, INC. | $199.64 | 2025 | Hemoblast Bellows |
| Alexion Pharmaceuticals, INC. | $167.87 | 2021-2024 | Soliris, Ultomiris |
| Tela Bio, INC. | $163.25 | 2021-2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Kerecis Limited | $103.63 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Acera Surgical, INC. | $91.78 | 2024-2025 | Restrata Wound Matrix |
| Csl Behring | $80.79 | 2019-2021 | |
| Smith+Nephew, INC. | $80.24 | 2021-2023 | Pico |
| Teleflex LLC | $63.17 | 2024 | Arrow |
| Depuy Synthes Sales INC. | $52.85 | 2021-2023 | Matrixrib |
| Musculoskeletal Transplant Foundation INC. | $50.92 | 2023-2025 | |
| Portola Pharmaceuticals, LLC | $50.50 | 2019-2020 | |
| Chiesi USA, INC. | $49.54 | 2023-2025 | Cleviprex |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $49.18 | 2019-2020 | |
| Baxter Healthcare | $46.84 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $41.11 | 2022-2023 | Andexxa |
| Becton, Dickinson and Company | $37.67 | 2020 | |
| Masimo Corporation | $22.69 | 2024 | Set and Rainbow Set |
| Humacyte Global, INC. | $19.24 | 2025 | Symvess |
| Ceribell, INC. | $18.58 | 2025 | Pocket Eeg Device |
| Urgo Medical North America, LLC | $18.57 | 2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Ucb, INC. | $18.47 | 2024 | Briviact |
| Mesh Suture INC | $18.31 | 2025 | |
| Melinta Therapeutics, LLC | $17.66 | 2025 | Rezzayo |
| Boston Scientific Corporation | $14.05 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Knight listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.